Cleared Special

K120229 - ENVOY DISTAL ACCESS GUIDING CATHETER

K120229 is an FDA 510(k) clearance for ENVOY DISTAL ACCESS GUIDING CATHETER, manufactured by Codman & Shurtleff, Inc.. The device is a Class 2 Cardiovascular device with product code DQY cleared through the Special 510(k) pathway after a 30-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2012
Decision
30d
Days
Class 2
Risk

K120229 is an FDA 510(k) clearance for the ENVOY DISTAL ACCESS GUIDING CATHETER. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Codman & Shurtleff, Inc. (Raynham, US). The FDA issued a Cleared decision on February 24, 2012 after a review of 30 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Codman & Shurtleff, Inc. devices

FDA 510(k) Submission Details - K120229

510(k) Number K120229 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 25, 2012
Decision Date February 24, 2012
Days to Decision 30 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
95d faster than avg
Panel avg: 125d · This submission: 30d
Pathway characteristics
Modification to existing cleared device.

DQY Device Classification - Class 2, Special Controls

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 673
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K120229.
EXCELSIOR XT-27 MICROCATHETER
K113778 · Stryker Neurovascular · Apr 2012
M2 NAVIGATION CATHETER AND GUIDELINER NAVIGATION CATHETER
K112100 · Vascular Solutions, Inc. · Mar 2012
CONCENTRIC BALLOON GUIDE CATHETER
K112404 · Concentric Medical, Inc. · Mar 2012
VALET MICRO CATHETER
K112035 · Volcano Corporation · Jan 2012
GUIDELINER V2 CATHETER
K112082 · Vascular Solutions, Inc. · Dec 2011
CLEARWAY RX NB CATHETER
K113112 · Atrium Medical Corp. · Nov 2011